In a study carried out in mice at the University of Chicago, researchers found that lasofoxifene outperformed fulvestrant, the current gold-standard drug, in reducing or preventing primary tumor growth. It also was more effective ...
May 13, 2021
0
419
(HealthDay)—More patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2-negative breast cancer have been treated with neoadjuvant endocrine therapy (NET) due to COVID-19, according to a ...
May 3, 2021
0
5
A small proportion of women who receive anti-estrogen treatment after breast cancer surgery have worse outcomes. This is associated with mutations in the estrogen receptor gene, according to a study from Lund University now ...
Apr 22, 2021
0
7
Invasive lobular carcinoma (ILC) is a type of breast cancer that begins in the milk-producing glands (lobules) of the breast. It covers 10 to 15% of all breast cancer cases, has a high risk of late recurrence, unique metastatic ...
Feb 22, 2021
0
6
Oral contraceptives are implicated in slightly increasing breast cancer risk. This birth control method contains forms of estrogen, a hormone that binds ERalpha (estrogen receptor alpha), to alter the reproductive cycle. ...
Aug 10, 2020
0
2
One member of a larger family of oxygen sensing enzymes could offer a viable target for triple negative breast cancer (TNBC), UTSW researchers report in a new study. The findings, published online this week in Cancer Discovery, ...
Jul 22, 2020
0
4994
The androgen receptor is the primary driver of the initiation and growth of prostate cancer, the second-leading cause of death in men. Looking to have a better understanding of how the androgen receptor works in cancer, researchers ...
Jul 14, 2020
0
6
Genetics may explain why some women gain weight when using a popular method of birth control, researchers say.
Jun 9, 2020
0
38
A woman's genetic make-up may cause her to gain weight when using a popular form of birth control, according to a study from researchers at the University of Colorado Anschutz Medical Campus.
May 12, 2020
0
0
Activating the G protein-coupled estrogen receptor (GPER)—a receptor found on the surface of many normal and cancer tissues—has been shown to stop pancreatic cancer from growing, but may also make tumors more visible ...
May 4, 2020
0
155
